{
    "2021-11-01": [
        [
            {
                "time": "",
                "original_text": "图解6大药店：门店扩张快，利润波动大",
                "features": {
                    "keywords": [
                        "门店扩张",
                        "利润波动",
                        "药店"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "太平洋：给予益丰药房买入评级，目标价位59.7元",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "买入评级",
                        "目标价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "安信证券：给予益丰药房买入评级，目标价位60.0元",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "买入评级",
                        "目标价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "图解益丰药房三季报：第三季度单季净利润同比增11.70%",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "三季报",
                        "净利润",
                        "同比增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "私募大佬放大招！看邓晓峰、冯柳、裘国根等最新持仓",
                "features": {
                    "keywords": [
                        "私募",
                        "大佬",
                        "持仓",
                        "邓晓峰",
                        "冯柳",
                        "裘国根"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【医药-马帅】益丰药房：疫情扰动下2021Q3业绩增长放缓，四季度业绩有望环比改善",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "疫情",
                        "业绩增长",
                        "放缓",
                        "四季度",
                        "环比改善"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}